The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Neuronetics Inc shares valued at $13,020,000 were sold by Madryn Asset Management, LP on Aug 08 ’25. At $3.72 per share, Madryn Asset Management, LP sold 3,500,000 shares. The insider’s holdings dropped to 1,142,351 shares worth approximately $2.27 million following the completion of this transaction.
Also, MADRYN HEALTH PRTS II (CAY MAS purchased 2,925,554 shares, netting a total of over 10,883,061 in proceeds.
Before that, MADRYN HEALTH PARTNERS II, LP had added 192,806 shares to its account. In a trade valued at $717,238, the 10% Owner bought Neuronetics Inc shares for $3.72 each.
As published in a research note from William Blair on August 13, 2024, Neuronetics Inc [STIM] has been rated down from an Outperform to a Mkt perform. Analysts at William Blair downgraded the stock from ‘”an Outperform”‘ to ‘”a Mkt perform”‘ outlook in a report released in mid October. As of October 13, 2021, BTIG Research has decreased its “Buy” rating to a “Neutral” for STIM. Earlier on January 22, 2021, William Blair upgraded its rating. Their new recommendation was “an Outperform” for STIM stock which previously was a “a Mkt perform”.
Analyzing STIM Stock Performance
On last trading session, Neuronetics Inc [NASDAQ: STIM] rose 2.84% to $1.99. The stock’s lowest price that day was $1.91, but it reached a high of $2.03 in the same session. During the last five days, there has been a surge of approximately 10.56%. Over the course of the year, Neuronetics Inc shares have dropped approximately -19.11%.
Is Neuronetics Inc subject to short interest?
Stocks of Neuronetics Inc saw a sharp rise in short interest on 2025-12-31 jumping by 1.55 million shares to 7.55 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 6.0 million shares. A jump of 20.5% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.18 of the overall float, the days-to-cover ratio (short ratio) jumped to 6.18.
Which companies own the most shares of Neuronetics Inc (STIM)?
In terms of Neuronetics Inc share price expectations, FactSet research, analysts set an average price target of 8 in the next 12 months, up nearly 314.51% from the previous closing price of $1.93. Analysts anticipate Neuronetics Inc stock to reach 8 by 2026, with the lowest price target being 8. In spite of this, 2 analysts ranked Neuronetics Inc stock as Buy at the end of 2026. On February 06, 2020, BTIG Research assigned a price target of “a Buy” to the stock and initiated coverage with a $11.
